Short Interest in Femasys Inc. (NASDAQ:FEMY) Increases By 74.5%

Femasys Inc. (NASDAQ:FEMY) was the target of a large growth in short interest in March. As of March 15th, there was short interest totalling 1,150,000 shares, a growth of 74.5% from the February 28th total of 658,900 shares. Based on an average daily trading volume, of 391,100 shares, the days-to-cover ratio is presently 2.9 days. Currently, 5.9% of the company’s stock are sold short.

Femasys Trading Down 3.4 %

Shares of NASDAQ:FEMY opened at $1.29 on Monday. The company has a current ratio of 3.94, a quick ratio of 3.26 and a debt-to-equity ratio of 0.86. The company has a market capitalization of $29.54 million, a PE ratio of -1.59 and a beta of -2.85. Femasys has a 12-month low of $0.86 and a 12-month high of $1.84. The business’s fifty day simple moving average is $1.41 and its 200-day simple moving average is $1.23.

Femasys (NASDAQ:FEMY) last announced its earnings results on Thursday, March 27th. The company reported ($0.23) EPS for the quarter, topping analysts’ consensus estimates of ($0.25) by $0.02. Femasys had a negative net margin of 1,435.77% and a negative return on equity of 141.49%. The business had revenue of $0.58 million during the quarter, compared to the consensus estimate of $1.66 million. As a group, equities research analysts predict that Femasys will post -0.86 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Separately, HC Wainwright reaffirmed a “buy” rating and issued a $15.00 price objective on shares of Femasys in a research note on Friday.

Institutional Investors Weigh In On Femasys

Several institutional investors have recently bought and sold shares of the company. Geode Capital Management LLC increased its holdings in shares of Femasys by 4.7% during the fourth quarter. Geode Capital Management LLC now owns 216,164 shares of the company’s stock valued at $238,000 after acquiring an additional 9,681 shares in the last quarter. XTX Topco Ltd increased its stake in Femasys by 123.9% during the 3rd quarter. XTX Topco Ltd now owns 32,535 shares of the company’s stock valued at $36,000 after purchasing an additional 18,004 shares in the last quarter. Virtu Financial LLC purchased a new position in shares of Femasys in the fourth quarter worth $25,000. Jane Street Group LLC acquired a new stake in shares of Femasys during the fourth quarter worth $30,000. Finally, Northern Trust Corp grew its holdings in shares of Femasys by 42.6% during the fourth quarter. Northern Trust Corp now owns 126,096 shares of the company’s stock valued at $139,000 after buying an additional 37,675 shares during the last quarter. 65.27% of the stock is currently owned by institutional investors and hedge funds.

About Femasys

Femasys Inc, a biomedical company, develops therapeutic and diagnostic solutions to address unmet women healthcare needs worldwide. The company provides FemVue saline-air device, a contrast-generating product in the United States, Canada, Japan, and Hong Kong; FemCath, a cornual balloon catheter, a single intrauterine directional delivery product that allows for selective evaluation of an individual fallopian tube; and FemCerv, a biopsy device for endocervical curettage, which can be used to sample cervical cells and tissue circumferentially with sample containment within the device to minimize contamination.